Emerging evidence suggests that GLP-1RAs may serve as promising neuroprotectors in glaucoma
Patients taking GLP-1 medications who are scheduled for colonoscopy should proactively communicate with both their prescribing physician and the gastroenterology team to ensure safe procedural planning
Moderate aerobic activity (150 min/week)
Diabetes Care 34:22202224 Agostini F, Masato A, Bubacco L, Bisaglia M (2022) Metformin repurposing for Parkinson disease therapy: opportunities and challenges
It activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors concurrently
Semaglutide, in the phase 3 STEP 1 trial, produced roughly 14.9% at the 2.4 mg dose over 68 weeks, versus about 2.4% for placebo a treatment difference of about 12.4 percentage points